Matthew W. Foehr - May 2, 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
May 2, 2022
Transactions value $
$111,195
Form type
4
Date filed
5/3/2022, 04:12 PM
Previous filing
Feb 16, 2022
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Purchase $111K +45K +67.92% $2.47 111K May 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.